Formation strategies, mechanism of intracellular delivery and potential clinical applications of pH-sensitive liposomes

被引:58
作者
Liu, Xin [1 ]
Huang, Guihua [1 ]
机构
[1] Shandong Univ, Sch Pharmaceut Sci, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China
关键词
pH-sensitive liposomes; Triggered release; Drug delivery; Gene therapy; Vaccine; Magnetic resonance imaging (MRI);
D O I
10.1016/j.ajps.2013.11.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
pH-sensitive liposomes are designed to specifically triggered release the loaded drugs in response to the change of pH in the surrounding serum. So pH-sensitive liposomes can effectively deliver drug or gene fragments into the cytoplasm via the endocytotic pathway. Furthermore, pH-sensitive liposomes can be successfully used in clinical if they enable the encapsulated drugs to be targeted to pathological tissues (such as primary tumors, metastases, local ischemia, inflammation and infection) of the body in which pH is less than the normal physiological value. That's the reason why a growing amount of literatures described the development and applications of pH-sensitive liposomes to improve the therapeutic index of the encapsulated active ingredients. In this review, the commonly used pH-sensitive molecules for pH-sensitive liposome and the mechanisms of intracellular delivery of pH-sensitive liposomes were addressed. Besides, the potential clinical applications were fully discussed in detail with an expectation to contribute to the clinical research of pH-sensitive liposomes. (C) 2013 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All rights reserved.
引用
收藏
页码:319 / 328
页数:10
相关论文
共 95 条
[1]   Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: A multicentric observational study [J].
Aiguabella, Maria ;
Falip, Merce ;
Villanueva, Vicente ;
de la Pena, Pilar ;
Molins, Albert ;
Garcia-Morales, Irene ;
Saiz, Rosa Ana ;
Pardo, Julio ;
Tortosa, Diego ;
Sansa, Gemma ;
Miro, Julia .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2011, 20 (01) :60-64
[2]   Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation [J].
Akita, Hidetaka ;
Kogure, Kentaro ;
Moriguchi, Rumiko ;
Nakamura, Yoshio ;
Higashi, Tomoko ;
Nakamura, Takashi ;
Serada, Satoshi ;
Fujimoto, Minoru ;
Naka, Tetsuji ;
Futaki, Shiroh ;
Harashima, Hideyoshi .
JOURNAL OF CONTROLLED RELEASE, 2010, 143 (03) :311-317
[3]  
Allen TM, 2002, CELL MOL BIOL LETT, V7, P217
[4]   LIPOSOMES AS IMMUNOLOGICAL ADJUVANTS [J].
ALLISON, AC ;
GREGORIADIS, G .
NATURE, 1974, 252 (5480) :252-252
[5]   Environmentally responsive peptides as anticancer drug carriers [J].
Aluri, Suhaas ;
Janib, Siti M. ;
Mackay, J. Andrew .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (11) :940-952
[6]   Lipid A and liposomes containing lipid A as antigens and adjuvants [J].
Alving, Carl R. ;
Rao, Mangala .
VACCINE, 2008, 26 (24) :3036-3045
[7]   Immunogenicity and protectivity of a new liposomal hepatitis A vaccine [J].
Ambrosch, F ;
Wiedermann, G ;
Jonas, S ;
Althaus, B ;
Finkel, B ;
Gluck, R ;
Herzog, C .
VACCINE, 1997, 15 (11) :1209-1213
[8]   Synthesis of calcium phosphate-binding liposome for drug delivery [J].
Anada, Takahisa ;
Takeda, Yoichi ;
Honda, Yoshitomo ;
Sakurai, Kazuo ;
Suzuki, Osamu .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) :4148-4150
[9]  
Angelos S, 2007, J PHYS CHEM C, V111, P6589, DOI 10.1021/jp0707211
[10]   Targeted transfection increases siRNA uptake and gene silencing of primary endothelial cells in vitro - A quantitative study [J].
Asgeirsdottir, Sigridur A. ;
Talman, Eduard G. ;
de Graaf, Inge A. ;
Kamps, Jan A. A. M. ;
Satchell, Simon C. ;
Mathieson, Peter W. ;
Ruiters, Marcel H. J. ;
Molema, Grietje .
JOURNAL OF CONTROLLED RELEASE, 2010, 141 (02) :241-251